ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,626.02
      0.54%
      US Tech 100
      18,986.40
      0.30%
      Dow Jones
      41,393.78
      0.72%
      Brent Oil
      71.825
      0.00%
      Bitcoin
      59,974.41
      -1.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Cryptocurrencies
      4. COIN
      5. (Cryptocurrency:EVRUSD)

      6. (Cryptocurrency:EVRUSD) News

      EVRUSD

      (EVRUSD)

      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      09/14/20246:30AMPR Newswire (Canada)L'opposition libérale presse le nouveau ministre d'agir maintenant et de mieux planifier pour régler la crise en francisation
      09/14/20246:26AMPR Newswire (US)Sunwoda Inside at RE+ 2024: Showcasing Comprehensive Energy Storage Solutions Across the Full Industrial Chain
      09/14/20246:00AMPR Newswire (Canada)Journée internationale de la démocratie - La FNCC-CSN rappelle l'importance des médias d'information
      09/14/20245:22AMPR Newswire (US)Sineng Electric Expands U.S. Operations with New Service Center in Texas
      09/14/20245:22AMPR Newswire (Canada)Sineng Electric Expands U.S. Operations with New Service Center in Texas
      09/14/20245:18AMPR Newswire (US)Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
      09/14/20245:00AMPR Newswire (US)Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development TimelinesNASDAQ:NUVLNuvalent Inc
      09/14/20244:15AMBusiness WirePfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung CancerNYSE:PFEPfizer Inc
      09/14/20244:15AMGlobeNewswire Inc.Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024NASDAQ:CGEMCullinan Therapeutics Inc
      09/14/20244:06AMPR Newswire (US)Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
      09/14/20244:00AMBusiness WireSVTA Announces New Board Officers
      09/14/20244:00AMBusiness WireIrdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience
      09/14/20244:00AMPR Newswire (US)Inside Flagright: Our Approach to Hiring and Team Growth
      09/14/20243:59AMBusiness WireSCFがニューパーク・フルード・システムズを買収NYSE:NRNewpark Resources Inc
      09/14/20243:30AMGlobeNewswire Inc.Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
      09/14/20243:15AMAlliance NewsAlliance NewsUS President Biden, UK PM Starmer put off Ukraine missiles decision
      09/14/20243:15AMBusiness WireKEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Overall Survival (OS) Versus Trastuzumab and Chemotherapy Alone in First-Line Treatment of Patients With HER2-Positive Advanced Gastric or GEJ AdenocarcinomaNYSE:MRKMerck and Co Inc
      09/14/20243:14AMAlliance NewsAlliance NewsHarris, Trump campaign in US battlegrounds as migrant row intensifies
      09/14/20243:10AMAlliance NewsAlliance NewsTOP NEWS: China retail sales, industrial production slow in August
      09/14/20243:10AMPR Newswire (US)RYBREVANT® (amivantamab-vmjw) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancerNYSE:JNJJohnson and Johnson
      09/14/20243:10AMGlobeNewswire Inc.Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data AnalysisNASDAQ:ACRVAcrivon Therapeutics Inc
      09/14/20243:09AMAlliance NewsAlliance NewsChina says German ships in Taiwan Strait "increase security risks"
      09/14/20243:09AMAlliance NewsAlliance NewsUK PM Starmer says serious and ambitious about reset with EU
      09/14/20243:05AMBusiness WirePositive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024NYSE:NUVBPanacea Acquisition Corp
      09/14/20243:05AMGlobeNewswire Inc.Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous TreatmentsEU:TNGTransgene SA
      09/14/20243:01AMGlobeNewswire Inc.NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024NASDAQ:NCNANuCana PLC
      09/14/20243:00AMGlobeNewswire Inc.Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancerNASDAQ:IMCRImmunocore Holdings PLC
      09/14/20243:00AMGlobeNewswire Inc.Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024NASDAQ:STROSutro Biopharma Inc
      09/14/20243:00AMGlobeNewswire Inc.Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid TumorsLSE:AVCTAvacta Group Plc
      09/14/20243:00AMBusiness WireBicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024NASDAQ:BCYCBicycle Therapeutics PLC

      Your Recent History

      HUOB
      REQUSDT
      Request
      Delayed Upgrade Clock